Edwards Lifesciences Corp., EW is in the exchange NYSE and its industry is Medical Appliances & Equipment in the sector of Healthcare. Based in USA, Edwards Lifesciences Corp., EW has a market cap of 21118.79. Since its IPO date on the 3/27/2000, Edwards Lifesciences Corp., EW performance year to date is 24.82%. Today Edwards Lifesciences Corp., EW has gained 0.95%, with a current price of 99.52.
Ownership of the company is 0.40% for insider ownership while institutional ownership is 87.80%. The management of the company have seen the company have a payout ratio of 0.00%. Return of assets are at 13.40%, with return on investment at 15.90%.
In terms of debt levels and profit levels, Edwards Lifesciences Corp., EW is seeing a long-term debt/equity of 0.26. While Total debt/equity is 0.26. With a profit margin of 19.80%, this is combined with a gross margin of 74.60%, and operating margin of 24.70%. Edwards Lifesciences Corp. ability to meet debt levels, with a current ratio of 4, while the quick ratio is 3.2.
For the last year Edwards Lifesciences Corp., EW has seen a EPS growth of -39.80%. A performance for the year of 38.41%. The 52-week high is -11.14%, and the 52-week low is 59.16%. The average volume for Edwards Lifesciences Corp., EW is 643470.
With a target price of 117.59, can Edwards Lifesciences Corp., EW reach this target? Looking at the value indicators of Edwards Lifesciences Corp., EW. Edwards Lifesciences Corp. has a P/E of 42 and a forward P/E of 29.99. Perhaps the more useful indicator than P/E, is PEG which has a value of 2.5. Edwards Lifesciences Corp. also has a P/S and a P/B of 8.12 and 9.14 respectively. For P/cash, Edwards Lifesciences Corp. has a value of 22.19, while it is 44.92 for P/free cash flow.
At the current price of 99.52, Edwards Lifesciences Corp. has a dividend yield of *TBA. We see a return on equity of 21.60%.
Looking more long-term Edwards Lifesciences Corp., is projected to get an EPS growth for the next five years of 16.82%. In the short-term an EPS growth of 18.66% in the next year is forecasted. This is after a EPS growth of -39.80% for this year and for the last five years a 19.70% growth has been seen.